Inventor

RUDDY STEPHEN B

US31 patents

⚠️ This page may combine multiple inventors who share the name “RUDDY STEPHEN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RUDDY STEPHEN B

ELAN PHARMA INT LTD

Compositions having a combination of immediate release and controlled release characteristics

Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate

Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate

Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract

Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors

Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers

Methods of treatment using nanoparticulate fenofibrate compositions

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions

Nanoparticulate fibrate formulations

Nanoparticulate fibrate formulations

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions

Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors

STERLING WINTHROP INC

Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract

X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract

Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract

Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract

X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays

NANOSYSTEMS LLC

Nanoparticles containing the R(-)enantiomer of ibuprofen

Barium salt formulations stabilized by non-ionic and anionic stabilizers

Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays

EASTMAN KODAK CO

Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays

Isolation of ultra small particles

NANO SYS LLC

Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents

Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers

ELAN PHARMA INTERNATIONAL LIMI

Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers

FOURNIER LAB IRELAND LTD

Nanoparticulate fibrate formulations

FLAK PHARMA INTERNATIONAL LTD

Rapidly disintegrating solid oral dosage form

VAGHEFI FARID

Abuse-resistant pharmaceutical compositions

COOPER EUGENE R

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions

STERLING WINTRHOP INC

X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays